Stealth Adapted Viruses Linked To Autism And Other Diseases

Mar 18, 2005
Author: W. John Martin, M.D., Ph.D.
Source: The Autism Autoimmunity Project (TAAP)

A lot of effort and resources within the autism community have been misdirected. Consequently, the epidemic continues. I am very confident autism will eventually be recognized as having a viral cause. This delay will be lessened if parents simply consider the facts and sort through the political and economic agendas that bias what they are mainly being presented.

The important facts are:

1. The cellular immune system does not effectively recognize all viruses. Effective immune recognition is generally restricted to only a few viral components. For example cytomegalovirus (a type of herpesvirus) has nearly 200 proteins yet over 90% of the cytotoxic T cell immune response is directed to only 3 viral components. By a process called “stealth-adaptation” a virus can lose these critical components and yet can retain or regain the ability to cause cell damage. I have DNA sequence data confirming this mechanism. More importantly, I have directly observed animals inoculated with stealth adapted viruses. The animals become extremely sick with widespread tissue damage, including extensive damage to the brain. Yet there is no inflammatory response; the usual hallmark of an infectious process. I have seen similar brain damage in several patients from whom I have cultured cell damaging (cytopathic) viruses. Interestingly, the animals largely recover from their illness over time (discussed later).

2. Unlike other organs in the body, the brain is uniquely sensitive to virus induced cell damage. With other organs, there is an overall uniform function. This means that limited localized damage in one area of these organs can be easily compensated by increased activity elsewhere. The brain functions differently with specific functions localized to distinct areas. Damage in one area cannot, therefore, be easily overcome. An exception is when the virus induces an auto-immune response such as in Hasimoto’s disease of the thyroid which is not uncommon among stealth virus infected patients. The other exception is cancer which only requires a single cell to go astray.

3. The big political block to my work came when I announced in 1995 that the prototype stealth-adapted cytomegalovirus was not of human origin, but was derived from the monkeys used to make live polio virus vaccines. I immediately notified FDA, CDC and Wyeth the manufacturer of live polio virus vaccine, but received a very cold reception. Adding to this block was the undisclosed study performed by FDA and Industry in 1972 showing that all of the African green monkeys being used for polio vaccine production were infected with simian cytomegalovirus (SCMV). FDA and Industry failed to disclose this finding not contemplating that viruses could cause chronic illnesses.

4. FDA recently did locate 8 licensed lots of polio vaccines released to the public in 1976. Three of the 8 lots have DNA of SCMV. FDA investigators say they cannot culture live virus from these lots, nor can they legally provide them for outside testing. in spite of this finding, FDA officials are still reluctant to follow up on my initial reports of stealth-adapted SCMV being isolated both from a patient with chronic fatigue syndrome and from a patient with a bi-polar manic depressive psychiatric illness.

5. It is technically difficult to culture stealth-adapted viruses because of a tendency for the cell damaging effect not to progress. The cultures undergo a repair process because of materials that accumulate in the culture fluids. I now recognize that these materials provide an alternative (non-mitochondria) source of cellular energy.

6. The polymerase chain reaction (PCR) can be used to detect some stealth-adapted viruses providing the small region being targeted by this reaction is conserved. Another difficulty with the PCR assay is that not all stealth-adapted viruses are derived from SCMV. Rather stealth-adaptation is a generic process that presumably can occur with all types of cytopathic viruses, e.g. EBV, HHV-6, HSV, etc.

7. An individual from Florida recently sent his own and his father’s blood to an animal testing laboratory. He had the smarts to pretend to be a veterinarian and to request tests on supposedly monkey blood. The result came back PCR positive for SCMV. I visited the testing lab. and assured myself they were able to clearly exclude human, rhesus monkey and baboon CMV and that the result was indeed positive for SCMV. The infected patient notified CDC of the results. CDC simply concluded they could not culture virus from his blood and the issue has seemingly been dropped. I received a “legal request” from the patient to test his blood. It induced the characteristic cytopathic effect caused by stealth-adapted viruses.

8. The Florida example underscores the infectious nature of stealth-adapted viruses. The gentleman became infected during a trip and soon after returning home saw marked behavioral changes in his son. His father visited briefly and he too became sick. There are many examples of “family illnesses of presumptive infectious origin” including many families in which there is an autistic child. The gentleman has markedly improved on ACE products (discussed below).

9. I have previously performed several double blind studies comparing stealth virus cultures from patients with various illnesses, including autism, with blood samples from volunteer donating blood for transfusions. A clear distinction was seen with the vast majority of patients testing positive compared to 10-15% of blood donors. According to the terms of the approved study, I could obtain no information on the health of those blood donors who tested positive. The implication of a contaminated National blood supply was hard for Public Health authorities to accept. In late 2002 I was encouraged (instructed) not to perform any further clinical testing and to ensure my compliance the clinical testing laboratory license was suspended. The only exceptions allowed were for research and, as I have recently learned, if legally requested.

10. The research focus returned to the issue that if there was no effective immune recognition, how does the body cope with stealth-adapted viruses. The answer was in the cultures that showed complete healing if inhibitory materials were allowed to accumulate. I had previously noted unusual complex structures in the brain cells of humans and stealth-virus inoculated animals. The mitochondria which normally supply the cell with energy were markedly disrupted, yet the cells were still surviving. It appeared as if the complex structures, and the materials accumulating in the cultures, were providing an alternative (non-mitochondria) source of cellular energy. I called these structures alternative cellular energy pigments (ACE pigments). ACE pigments were experimentally shown to provide an auxiliary defense mechanism that is particularly relevant in defending against stealth-adapted viruses.

11. The importance of the ACE pathway has been convincingly demonstrated in the ease of therapy for conventional HSV oral and genital lesions. The ACE pathway in these lesions can be easily activated using a dye called neutral red followed by brief exposure to ultraviolet-A light. This approach also works well with shingles and post herpetic neuralgia and with genital warts caused by human papillomavirus. FDA was notified of these findings last October and are still trying to decide if they want to classify neutral red as a drug or as a medical device.

12. The obvious implication for autistic children is to activate and/or support the ACE pathway. I have been impressed with some preliminary responses and now want to see controlled studies. The current format for the herpes treatment is to have patients select a physician of their choice. The physicians are to evaluate the lesions before and the day after therapy. We can compensate the physician up to 0.00 from fees collected from participants willing to join an Institute of Progressive Medicine. I think we should do the same with autistic children.

13. It is clear that the pharmaceutical approach to many chronic illnesses has its limitations. The public needs to be better informed of developments outside the pharmaceutical industry. Good data need to be collected from well designed clinical trials.

14. I hope the foregoing will give a sense of optimism to parents struggling with autism and related illnesses. Research on stealth-adapted viruses has opened up a whole new approach to disease therapy. I would like to encourage individuals to visit the web site www.s3support.com and to consider participating in clinical trials as one of the bonuses of being a member of the Institute of Progressive Medicine. The web site has copies of various publications and supporting information.

15. Parents can also put political pressure on the system to begin to address autism as an unintended consequence of allowing cytomegaloviruses to contaminate polio vaccines. Infected parents are at risk of having autistic children. Such parents can be identified, but not if the Public Health system will not allow stealth virus testing or acquire the know-how to do this type of testing within their own facilities.

Kind regards,

W. John Martin, M.D., Ph.D.

DEFINITION * TREATMENT * PREVENTION
Autism is 1 in 150 children today, 1 in 68 families! TAAP (The Autism Autoimmunity Project) is a non-profit charity dedicated to obtaining funding for independent research into the cause, treatment and prevention of autism and other autoimmune disorders. Please visit our new website at http://www.TAAP.info and “TAAP into the Truth!”


Name
Email
http://
Message
  Textile help